Skip to Content

BAYER 40 (Stivarga 40 mg)

Generic Name: regorafenib

Pill with imprint BAYER 40 is Pink, Elliptical / Oval and has been identified as Stivarga 40 mg. It is supplied by Bayer HealthCare Pharmaceuticals Inc..

Stivarga is used in the treatment of colorectal cancer; hepatocellular carcinoma; gastrointestinal stromal tumor and belongs to the drug classes multikinase inhibitors, VEGF/VEGFR inhibitors. There is positive evidence of human fetal risk during pregnancy. Stivarga 40 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for BAYER 40

Stivarga 40 mg BAYER 40

Stivarga

Generic Name:
regorafenib
Imprint:
BAYER 40
Strength:
40 mg
Color:
Pink
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Multikinase inhibitors
VEGF/VEGFR inhibitors
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Bayer HealthCare Pharmaceuticals Inc.
Inactive Ingredients:
microcrystalline cellulose
croscarmellose sodium
magnesium stearate
silicon dioxide
ferric oxide red
ferric oxide yellow
soya lecithin
polyethylene glycol 3350
polyvinyl alcohol
magnesium silicate
titanium dioxide
povidone
Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide